Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced that it has partnered with Triumph Research Intelligence (TRI), a global company focused in centralized and risk-based quality management (RBQM) technology.
“We’re very excited about this collaboration with TRI, as it will enable us to deliver an even better service to our Sponsors,” said Matthew Healy, Vice President, Clinical Operations at Rho. “Having a fully validated tool that delivers the entire end-to-end RBQM processes is a key differentiator for us. It means that we can be confident in identifying and documenting potential study risks right from the start, then using the tools we can spot and manage emerging trends, acting much more quickly to target our onsite monitoring activities and focus our efforts on those areas that will improve data quality and better ensure patient safety.”
TRI’s RBQM technology platform optimizes trial quality by improving data reliability, patient safety and operational efficiency. Regulatory guidance requiring the adoption of RBQM has led to a rapid increase in demand for centralized and risk-based monitoring solutions from CROs and Sponsors.
“We’re delighted to be partnering with Rho as they are one of the leading CRO’s with a global reputation for excellence,” said Duncan Hall, CEO and Founder of TRI. “In a world of big data, it’s still people that have to make the decisions. Our RBQM technology platform, OPRA, will enable Rho and their Sponsors to make better informed decisions faster, leading to better quality trials and improved patient safety.”
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.